These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37197468)

  • 1. Novel Serine-Arginine Protein Kinase Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 May; 14(5):551-552. PubMed ID: 37197468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First evidence of a serine arginine protein kinase (SRPK) in leishmania braziliensis and its potential as therapeutic target.
    Pimentel DC; Leopoldo JR; Teixeira LF; Barros MVA; de Souza APM; Onofre TS; de Carvalho RL; Machado SA; Messias IG; Pinto CCS; Poleto MD; Diogo MA; Mariotini-Moura C; Bressan GC; Teixeira RR; Fietto JLR; Vasconcellos RS
    Acta Trop; 2023 Feb; 238():106801. PubMed ID: 36563831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory activity of trifluoromethyl arylamides derived from the SRPK inhibitor SRPIN340 and their potential use as vaccine adjuvant.
    Mendes FC; de Paiva JC; da Silva EQG; Santos MR; de Almeida Lima GD; Moreira GA; Silva LVG; de Melo Agripino J; de Souza APM; de Oliveira Mendes TA; Machado-Neves M; Teixeira RR; Silva-Júnior A; Fietto JLR; de Oliveira LL; Bressan GC
    Life Sci; 2022 Oct; 307():120849. PubMed ID: 35926588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimetastatic effect of the pharmacological inhibition of serine/arginine-rich protein kinases (SRPK) in murine melanoma.
    Moreira GA; Lima GDA; Siqueira RP; Barros MVA; Adjanohoun ALM; Santos VC; Barbosa ÉAA; Loterio RK; Paiva JC; Gonçalves VHS; Viol LCS; Marques-da-Silva EA; Júnior AS; Almeida MR; Fietto JLR; Machado-Neves M; Ferreira RS; Teixeira RR; Bressan GC
    Toxicol Appl Pharmacol; 2018 Oct; 356():214-223. PubMed ID: 30138656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Tyrosine Kinase 2 Inhibitors for Treating Autoimmune and Inflammatory Diseases.
    Sabnis RW
    ACS Med Chem Lett; 2024 Jun; 15(6):769-770. PubMed ID: 38894908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine-arginine protein kinases: a small protein kinase family with a large cellular presence.
    Giannakouros T; Nikolakaki E; Mylonis I; Georgatsou E
    FEBS J; 2011 Feb; 278(4):570-86. PubMed ID: 21205200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Compounds as TEAD Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Sep; 14(9):1152-1153. PubMed ID: 37736181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Indazole Compounds as TEAD Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Oct; 14(10):1334-1335. PubMed ID: 37849539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Tricyclic Compounds as KRAS Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 May; 14(5):555-556. PubMed ID: 37197476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Quinoline Compounds as KRAS Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Jun; 14(6):707-708. PubMed ID: 37312857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Heteroaryl Compounds as CD73 Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2024 Jun; 15(6):775-776. PubMed ID: 38894910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel 2,7-Naphthyridine Compounds as MASTL Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2024 Jun; 15(6):748-749. PubMed ID: 38894901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Pyrazoloquinoline Compounds as KRAS Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Aug; 14(8):1045-1046. PubMed ID: 37583830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imidazopyridine Compounds as ERK5 Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2024 Jun; 15(6):777-778. PubMed ID: 38894904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel PARP1 Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2024 Feb; 15(2):161-162. PubMed ID: 38352834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel PARP7 Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Dec; 14(12):1615-1616. PubMed ID: 38116422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel PARP1 Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Dec; 14(12):1629-1630. PubMed ID: 38116419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel CD73 Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2024 May; 15(5):571-572. PubMed ID: 38746902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel IL4I1 Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Jun; 14(6):700-701. PubMed ID: 37312856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Phosphorylpurinone Compounds for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2024 Apr; 15(4):441-442. PubMed ID: 38628787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.